Pneumococcus - a global challenge
COVID-19 may have stopped the world in its tracks for the past two years, but other microbes such as the pneumococcus continue to kill millions of people around the world every year without making the headlines.
Pneumococcal infections range in severity from relatively mild upper respiratory tract conditions, right through to pneumonia, meningitis and febrile bacteremia. Their impact on both the very young and elderly populations is significant, with the WHO estimating more than a million children die from Pneumococcal infections every year.
To understand more about pneumococcus, and how researchers are tackling and solving this major global health challenge, the University of Adelaide is hosting a public panel discussion.
- When: Tuesday 8 November from 5-6 pm
- Where: Adelaide Health & Medical Sciences building, G030 lecture theatre. 4 North Terrace.
- Register: Book to attend the event live or online.
Anchored by award-winning author, scientist, TV personality and Senior South Australian of the Year, Professor Rob Morrison OAM, the event features an expert panel.
2017 South Australian Scientist of the Year, Director of the Research Centre for Infectious Diseases at the University of Adelaide and global authority on the pneumococcus, Professor James Paton (School of Biological Sciences), will explore both the impact of pneumococcal infection and the global research being undertaken to minimise that impact.
He is joined by non-executive director of GPN Vaccines and Fellow of the International Society of Vaccines, Dr Manon Cox, who led the development of Flublok at Protein Sciences an FDA approved recombinant protein-based influenza vaccine.
The event promises insights into the science of vaccines and the diseases they thwart.